Cochrane Abstracts
Non‐targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐targeted Immunosuppressive and Immunomodulatory Therapies for Idiopathic Inflammatory Myopathies." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440787/all/Gut_microbiome‐based_interventions_for_the_management_of_obesity_in_children_and_adolescents_aged_up_to_19_years.
Non‐targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440787/all/Gut_microbiome‐based_interventions_for_the_management_of_obesity_in_children_and_adolescents_aged_up_to_19_years. Accessed June 15, 2026.
Non‐targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440787/all/Gut_microbiome‐based_interventions_for_the_management_of_obesity_in_children_and_adolescents_aged_up_to_19_years
Non‐targeted Immunosuppressive and Immunomodulatory Therapies for Idiopathic Inflammatory Myopathies [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 June 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440787/all/Gut_microbiome‐based_interventions_for_the_management_of_obesity_in_children_and_adolescents_aged_up_to_19_years.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies
ID - 440787
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440787/all/Gut_microbiome‐based_interventions_for_the_management_of_obesity_in_children_and_adolescents_aged_up_to_19_years
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
